Login to Your Account

Pharnext Raises $10M for Drug Cocktail, Biomarker Programs

By Cormac Sheridan
Staff Writer

Wednesday, February 15, 2012
Pharnext SAS has unveiled €8 million (US$10.5 million) in new funding, which will enable the network pharmacology company to take its second drug development program, in Alzheimer's disease, into the clinic this year.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription